Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-23 Sale | 2025-01-27 7:22 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 959 | $21 | $20,139 | 35,781 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 9:28 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 32,729 | $19.82 | $648,824 | 272,122 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 9:28 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 37,184 | $19.8 | $736,059 | 527,201 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 9:27 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 45,167 | $19.77 | $893,095 | 455,433 (Direct) | View |
| 2025-01-02 Sale | 2025-01-06 6:07 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 11,520 | $19.05 | $219,456 | 3,764,252 (Direct) | View |
| 2024-12-27 Sale | 2024-12-30 5:12 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 2,850 | $20 | $57,000 | 36,740 (Direct) | View |
| 2024-12-23 Sale | 2024-12-23 4:39 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 12,563 | $19.59 | $246,109 | 3,775,772 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 26,712 | $21.24 | $567,486 | 3,788,335 (Direct) | View |
| 2024-12-16 Sale | 2024-12-18 6:19 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 7,495 | $21.97 | $164,665 | 40,378 (Direct) | View |
| 2024-12-16 Sale | 2024-12-18 6:18 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 5,547 | $21.91 | $121,556 | 124,167 (Direct) | View |
| 2024-12-16 Sale | 2024-12-18 6:15 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 8,994 | $21.91 | $197,059 | 21,211 (Direct) | View |
| 2024-03-22 Purchase | 2024-11-15 8:34 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 2,400 | $25.91 | $62,176 | 36,080 (Indirect Direct) | View |
| 2024-07-02 Sale | 2024-07-03 5:27 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 9,394 | $25.28 | $237,480 | 127,107 (Direct) | View |
| 2024-05-02 Sale | 2024-05-06 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,799 | $23.31 | $41,935 | 30,205 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 6:05 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 6,000 | $28.03 | $168,180 | 204,851 (Direct) | View |
| 2024-03-18 Purchase | 2024-03-20 7:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 3,000 | $27.66 | $82,990 | 33,680 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 5:54 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 40,000 | $35.19 | $1,407,600 | 400,600 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 5:25 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $32.35 | $1,860,019 | 4,066,774 (Direct) | View |
| 2024-01-12 Sale | 2024-01-17 6:32 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 7,940 | $36.89 | $292,904 | 210,851 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 2,911 | $38.06 | $110,788 | 129,711 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 3,934 | $38.07 | $149,759 | 47,870 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 3,147 | $38.06 | $119,787 | 60,778 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 4,720 | $38.1 | $179,813 | 32,001 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 5:17 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 74 | $33.89 | $2,508 | 136,501 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 5:16 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 16,104 | $35.27 | $567,910 | 440,600 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 5:16 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer | 8,303 | $35.26 | $292,804 | 198,497 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 8:02 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 38,443 | $34.69 | $1,333,529 | 218,791 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 7:58 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 33,190 | $34.36 | $1,140,362 | 464,385 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 5:25 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 9,952 | $31.01 | $308,637 | 3,715,048 (Direct) | View |
| 2023-12-20 Sale | 2023-12-22 5:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 12,000 | $28.54 | $342,480 | 3,725,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-07 Option Award | 2025-02-10 6:23 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 9,550 | $20.1 | 3,773,802 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 5:57 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | INGRAM DOUGLAS S Director | 38,396 | $20.09 | 38,396 (Direct) | View |
Ownership | 2025-02-07 5:57 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | INGRAM DOUGLAS S Director | 0 | $0 | 0 (Direct) | View |
| 2025-01-04 Option Award | 2025-01-07 9:28 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 100,000 | $0 | 272,122 (Direct) | View |
| 2025-01-04 Option Award | 2025-01-07 9:28 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 100,000 | $0 | 527,201 (Direct) | View |
| 2025-01-04 Option Award | 2025-01-07 9:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 100,000 | $0 | 455,433 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 6:05 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 16,733 | $22.99 | 37,944 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 6:05 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 16,733 | $22.99 | 39,590 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 6:05 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 16,733 | $22.99 | 57,111 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 6:04 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 16,733 | $22.99 | 77,514 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 6:04 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 16,733 | $22.99 | 131,490 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 6:04 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 16,733 | $22.99 | 47,163 (Direct) | View |
| 2024-12-18 Option Award | 2024-12-20 6:04 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 100,000 | $0 | 3,788,335 (Direct) | View |
| 2024-09-25 Ownership | 2024-11-15 8:34 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 5,650 | $0 | 36,080 (Direct) | View |
Ownership | 2024-11-15 8:34 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 0 | $0 | 36,080 (Indirect) | View |
Ownership | 2024-03-18 7:00 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 0 | $0 | 30,680 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 5:25 pm | 2015-02-06 2024-02-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $0 | 4,066,774 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 5:25 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $14.54 | 4,066,774 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 5:17 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 75,000 | $0 | 136,501 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 5:16 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 75,000 | $0 | 440,600 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 5:16 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer | 75,000 | $0 | 198,497 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 8:02 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 75,000 | $0 | 218,791 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 7:58 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 85,000 | $0 | 464,385 (Direct) | View |